This is a preview of subscription content, log in via an institution to check access.
Notes
2017 Canadian dollars
Reference
Johansen P, et al. Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada. PharmacoEconomics-Open : 29 Mar 2019. Available from: URL: https://doi.org/10.1007/s41669-019-0131-6
Rights and permissions
About this article
Cite this article
Semaglutide cost effective versus dulaglutide for type 2 diabetes. PharmacoEcon Outcomes News 825, 28 (2019). https://doi.org/10.1007/s40274-019-5794-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5794-9